correspond
address
email
mailsysueducn
cancer
figur
among
lead
caus
morbid
mortal
worldwid
number
new
case
expect
rise
next
decad
develop
novel
therapeut
agent
urgent
need
clinic
cancer
therapi
alphaviru
getahlik
viru
isol
china
genom
posit
singlestrand
rna
previous
identifi
alphaviru
natur
exist
oncolyt
viru
signific
anticanc
activ
differ
kind
cancer
eg
liver
cancer
bladder
cancer
colon
cancer
support
incom
clinic
trial
intraven
administr
alphaviru
cancer
patient
assess
safeti
adult
nonhuman
primat
previous
present
genom
sequenc
data
cynomolgu
macaqu
macaca
fasciculari
demonstr
ideal
anim
speci
viru
infect
studi
therefor
chose
cynomolgu
macaqu
either
sex
present
safeti
studi
oncolyt
viru
first
round
administr
five
experiment
macaqu
intraven
inject
six
time
oncolyt
viru
pfudos
week
compar
five
vehicleinject
control
anim
last
two
round
inject
complet
follow
month
way
first
round
bodi
weight
temperatur
complet
blood
count
clinic
biochemistri
cytokin
profil
lymphocyt
subset
neutral
antibodi
clinic
symptom
close
monitor
differ
time
point
magnet
reson
imag
also
perform
assess
possibl
enceph
arthriti
result
clinic
biochem
immunolog
medic
imag
patholog
evid
toxic
found
whole
process
studi
result
cynomolgu
macaqu
suggest
safeti
intraven
administr
oncolyt
viru
cancer
patient
futur
keyword
oncolyt
viru
cynomolgu
macaqu
safeti
viru
acknowledg
work
support
nation
natur
scienc
foundat
china
guangdong
provinci
scienc
technolog
project
guangdong
provinci
natur
scienc
foundat
grant
fundament
research
fund
central
univers
correspond
address
email
hmcpsuedu
rheumatoid
arthriti
ra
chronic
symmetr
autoimmun
diseas
character
synovi
inflamm
affect
primarili
small
diarthrodi
joint
none
current
treatment
cure
diseas
mesenchym
stem
cell
shown
maintain
immun
homeostasi
prevent
autoimmun
may
potenti
therapeut
approach
ra
recent
observ
gingivaderiv
mesenchym
stem
cell
gmsc
also
capac
inhibit
immun
respons
control
develop
sever
collageninduc
arthriti
cia
mice
depend
signal
pathway
partial
induct
treg
cell
moreov
gmsc
dramat
directli
inhibit
ranklmedi
osteoclast
format
well
bone
eros
cia
evalu
clinic
translat
valu
develop
human
anim
model
xenogvhd
demonstr
infus
gmsc
markedli
inhibit
human
pbmcsiniti
xenogen
graftversushostdiseas
gvhd
effect
request
ido
signal
importantli
effect
gmsc
significantli
better
bone
marrowderiv
mesenchym
stem
cell
bmsc
taken
togeth
manipul
gmsc
could
provid
promis
approach
cure
autoimmun
diseas
rheumatoid
arthriti
xenograftversushostdiseas
keyword
gmsc
rheumatoid
arthriti
gvhd
cia
acknowledg
work
part
support
grant
nih
nih
star
project
correspond
address
email
sachdevsidhu
utorontoca
recent
middl
east
respiratori
syndrom
coronaviru
merscov
ebola
zika
viru
outbreak
exemplifi
continu
threat
emerg
virus
human
health
inabl
rapidli
develop
effect
therapeut
countermeasur
mani
virus
includ
merscov
crimeancongo
hemorrhag
fever
viru
cchfv
encod
deubiquitin
dub
enzym
critic
viral
replic
pathogen
bind
remov
ubiquitin
ub
interferon
stimul
gene
cellular
protein
suppress
host
antivir
innat
immun
respons
varieti
viral
dub
vdub
includ
merscov
papainlik
proteas
respons
cleav
viral
replicas
polyprotein
replic
therebi
critic
compon
viral
replic
cycl
togeth
make
vdub
highli
attract
antivir
drug
target
howev
structur
similar
catalyt
core
vdub
human
dub
complic
develop
select
small
molecul
vdub
inhibitor
thu
develop
altern
strategi
target
vdub
activ
ration
protein
design
approach
report
use
phagedisplay
ubiquitin
variant
ubv
librari
rapidli
identifi
potent
highli
select
proteinbas
inhibitor
target
dub
domain
merscov
cchfv
ubv
bound
vdub
high
affin
specif
inhibit
deubiquitin
deisgyl
case
merscov
also
viral
replic
polyprotein
process
cocrystal
studi
reveal
critic
molecular
interact
ubv
merscov
cchfv
vdub
account
observ
bind
specif
high
affin
final
express
ubv
merscov
infect
reduc
infecti
progeni
titer
four
order
magnitud
demonstr
remark
potenc
ubv
antivir
agent
result
therebi
establish
strategi
produc
proteinbas
inhibitor
could
protect
divers
rang
virus
provid
ubv
via
mrna
protein
deliveri
technolog
transgen
techniqu
keyword
mer
cchfv
deubiquitinas
phage
display
ubiquitin
variant
protein
engin
inhibitor
design
antivir
drug
acknowledg
mk
support
divis
chemic
scienc
netherland
organ
scientif
research
nwocw
excel
chemic
research
echo
grant
blm
manitoba
research
chair
support
natur
scienc
engin
research
council
canada
nserc
grant
bbe
hold
nserc
postgradu
scholarship
pgsdoctor
wz
support
mitac
elev
program
fund
mitac
inc
centr
commerci
antibodi
biolog
ccab
sss
support
canadian
institut
health
research
cihr
grant
funder
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
correspond
address
email
lingbaodong
cmceducn
biofilm
format
abil
baumannii
associ
longterm
surviv
hospit
environ
equip
provid
resist
antibiot
present
studi
aim
observ
biofilm
format
abil
baumannii
clinic
isol
well
infect
diseas
therapi
influenc
biofilm
format
antimicrobi
therapi
total
baumannii
clinic
isol
collect
biofilm
abil
baumannii
test
crystal
violet
stain
assay
time
biofilm
abil
surfac
glass
polypropylen
condit
shake
stabl
minim
inhibitori
concentr
antibacteri
plankton
biofilm
biofilm
format
isol
test
use
microdilut
method
thirteen
isol
biofilm
format
abil
contain
miltdrug
resist
isol
compar
mic
plankton
biofilm
tigecyclin
colistin
resist
ratio
increas
respect
meanwhil
antibiot
resist
ratio
increas
fold
chang
mic
valu
antibacteri
rang
clinic
isol
strong
biofilm
abil
surfac
polypropylen
glass
show
strong
biofilm
abil
shake
condit
stabl
biofilm
format
could
lead
bacteri
resist
antibiot
clinic
therapi
failur
keyword
acinetobact
baumannii
biofilm
acknowledg
work
support
nation
natur
scienc
foundat
china
nsfc
correspond
address
email
lingbaodong
cmceducn
present
studi
aim
investig
molecular
resist
characterist
baumannii
biocid
fortyseven
clinic
isol
collect
suscept
commonli
use
biocid
test
incid
biocid
resist
gene
analyz
polymeras
chain
reaction
sequenc
addit
isol
exhibit
higher
minim
inhibitori
concentr
mic
biocid
determin
multilocu
sequenc
type
mlst
puls
field
gel
electrophoresi
pfge
revers
transcriptas
quantit
pcr
result
reveal
baumannii
show
differ
level
reduc
suscept
chlorhexidin
benzalkonium
bromid
ethanol
hydrogen
peroxid
especi
extens
resist
triclosan
ratio
report
biocid
resist
gene
baumannii
adej
abe
fabi
acei
sequenc
type
st
novel
st
identifi
clinic
isol
exhibit
higher
mic
triclosan
ethanol
belong
clone
complex
cc
major
clone
spread
hospit
two
distinct
pfge
pattern
identifi
isol
belong
pulsotyp
isol
belong
pulsotyp
b
clinic
isol
belong
pulsotyp
simultan
correspond
pulsotyp
b
gene
express
show
activ
efflux
appear
major
reason
acquir
triclosan
chlorhexidin
resist
meanwhil
fabi
acei
display
differ
express
higher
lower
isol
conclus
reduc
suscept
biocid
baumannii
extrem
sever
hospit
find
suggest
urgent
monitor
biocid
suscept
baumannii
ration
biocid
usag
clinic
keyword
acinetobact
baumannii
biocid
molecular
character
mlst
pfge
acknowledg
work
support
nation
natur
scienc
foundat
china
nsfc
correspond
address
email
pingji
whueducn
prenat
cigarett
smoke
exposur
report
increas
thymocyt
apoptosi
result
postnat
immun
impair
nicotin
one
lead
candid
cigarett
smoke
caus
immun
cell
apoptosi
howev
whether
prenat
nicotin
exposur
pne
induc
thymocyt
apoptosi
mechan
remain
unclear
studi
design
investig
effect
pne
immun
impair
offspr
observ
program
chang
thymocyt
apoptosi
vivo
explor
epigenet
mechan
proapoptot
effect
nicotin
vitro
result
show
pne
caus
immun
impair
femal
offspr
postnat
day
pnd
manifest
increas
product
ratio
serum
enhanc
apoptosi
total
thymocyt
singl
posit
thymocyt
observ
fetu
femal
offspr
pnd
expos
thymocyt
nicotin
vitro
h
found
nicotin
increas
nicotin
acetylcholin
receptor
nachr
express
activ
fa
apoptot
pathway
promot
thymocyt
apoptosi
concentrationdepend
manner
addit
nicotin
could
induc
tet
methylcytosin
dioxygenas
tet
express
fa
promotor
demethyl
abolish
sirna
transfect
moreov
nachr
specif
antagonist
treatment
abrog
nicotineinduc
increas
follow
fa
demethyl
fasmedi
apoptosi
conclus
find
firstli
report
nachr
activ
could
induc
demethyl
fa
thymocyt
result
upregul
fa
apoptot
pathway
provid
evid
elucid
pneinduc
program
thymocyt
apoptosi
keyword
prenat
nicotin
exposur
nachr
thymocyt
apoptosi
fa
immun
impair
acknowledg
work
support
grant
nation
natur
scienc
foundat
china
outstand
youth
scienc
fund
hubei
provinc
correspond
address
manf
er
stress
induc
secretori
protein
protect
effect
variou
neural
injuri
howev
involv
manf
inflamm
illustr
yet
studi
found
manf
mrna
upregul
peripher
blood
leukocyt
pbwc
patient
rheumatoid
arthriti
case
system
lupu
erythematosu
case
ankylos
spondyl
case
use
qpcr
meanwhil
manf
transcript
level
elev
pbwc
synovi
tissu
rabbit
osteoarthr
induc
methyl
bovin
serum
albumin
rat
rheumatoid
arthriti
induc
freund
complet
adjuv
bip
chop
also
upregul
inflammatori
synovium
result
suggest
inflamm
induc
er
stress
manf
express
clone
manf
construct
seri
mutat
within
transcript
factor
bind
site
found
bound
er
stress
respons
element
ers
site
upstream
manf
promot
activ
manf
transcript
use
luciferas
report
gene
technolog
chip
investig
interact
manf
use
coip
pulldown
doubl
immunofluoresc
label
found
tunicamycin
lp
caus
manf
reloc
nuclei
manf
interact
dna
bind
domain
ctermin
saplik
domain
manf
consequ
inhibit
transcript
activ
interf
bind
target
gene
promot
howev
manf
affect
total
level
cellular
consist
manf
suppress
express
target
gene
prolifer
inflammatori
synoviocyt
find
suggest
manf
may
neg
regul
inflamm
mediat
crosstalk
pathway
er
stress
therefor
upregul
manf
adapt
respons
inflammatori
condit
correspond
address
email
immunosuppress
predomin
caus
sepsi
mortal
due
lack
effect
treatment
investig
new
drug
base
anim
sepsi
model
close
resembl
clinic
situat
import
clp
immunosuppress
mice
model
carri
influenc
artesun
underli
mechan
investig
use
model
colon
tissu
cm
distal
cecum
ligat
punctur
steel
needl
establish
clp
mice
model
result
show
day
clp
surgeri
mice
present
low
level
proinflammatori
antiinflammatori
cytokin
well
high
bacteri
load
clp
group
challeng
pa
day
higher
sensit
mice
sham
group
result
show
day
clp
surgeri
turn
point
overinflamm
immunosuppress
obvious
increas
proinflammatori
cytokin
level
decreas
bacteri
load
lung
spleen
blood
well
mortal
clp
immunosuppress
mice
challeng
pa
protect
clp
immunosuppress
mice
sepsi
increas
proinflammatori
cytokin
releas
bacteri
clearanc
addit
increas
express
protein
activ
autophagi
also
implic
effect
conclus
day
clp
surgeri
turn
point
overinflamm
immunosuppress
repres
put
candid
sepsi
treatment
keyword
sepsi
immunosuppress
cecal
ligat
punctur
artesun
